Reduced risk of all-cancer and solid cancer in Taiwanese patients with rheumatoid arthritis treated with etanercept, a TNF-α inhibitor

Biologics has been widely used in the treatment of rheumatoid arthritis. We aimed to determine whether etanercept, a TNF-α inhibitor (TNFi) that is used to treat patients with rheumatoid arthritis (RA), affects cancer risk. This retrospective matched cohort study used data in the Registry of Catastr...

Descripción completa

Detalles Bibliográficos
Autores principales: Lan, Joung-Liang, Tseng, Chun-Hung, Chen, Jiunn-Horng, Cheng, Chi-Fung, Liang, Wen-Miin, Tsay, Gregory J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
6900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319502/
https://www.ncbi.nlm.nih.gov/pubmed/28207513
http://dx.doi.org/10.1097/MD.0000000000006055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319502/
https://www.ncbi.nlm.nih.gov/pubmed/28207513
http://dx.doi.org/10.1097/MD.0000000000006055

Ejemplares similares